Therefore, immune-related processes that are linked to the bone destruction may contribute to the generation of pain symptoms in metastatic breast cancer; thus bone-driven blocking of TGF-β may be an interesting approach to avoid pain syndromes in advanced breast cancer. Here, TGFB1 is linked to breast cancer.